Compare Globus Medical Inc. Class A Common Stock (GMED) vs Hershey Co (HSY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Globus Medical Inc. Class A Common Stock vs Hershey Co — how do they compare? Globus Medical Inc. Class A Common Stock trades at $76.58 (market cap $10.25B), while Hershey Co trades at $165.42 (market cap $32.76B). The key difference: Hershey Co is far larger — about 3.2× Globus Medical Inc. Class A Common Stock's market cap, and Hershey Co pays a 3.56% dividend while Globus Medical Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Globus Medical Inc. Class A Common Stock for 0 Days and Hershey Co for 135 Days on average.
| GMED | HSY | |
|---|---|---|
Market Cap | $10.25B | $32.76B |
Volume | 1,108,124 | 1,118,576 |
Sector | Health | Consumer Staples |
52-Week High | $96.82 | $236.28 |
52-Week Low | $58.33 | $157.61 |
Typical Hold Time | 0 Days | 135 Days |
Enterprise Value | $9.76B | $37.89B |
Dividend Yield | — | 3.56% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Globus Medical (GMED) trades at $76.32, showing minimal daily movement with a 0.1% gain. The stock demonstrates strong fundamental performance with consistent earnings beats in recent quarters and robust profitability metrics including 68.55% gross margins and 17.03% net income margins. Technical indicators suggest neutral positioning near key support at $73 with resistance at $74. Recent developments include new product showcases at industry conferences and upcoming Q3 earnings release.
GMED presents a compelling investment case with strong analyst support (72% buy rating) and 25% upside to consensus target of $95.13. The company maintains solid revenue growth trajectory and debt-free balance sheet, though investors should monitor competitive pressures in medical devices and potential margin compression as revenue scales. Near-term catalysts include Q3 earnings results expected November 5, 2026.
HSY trades at $164.25, up 0.25% on the day, with a bearish technical signal despite recent earnings beats. The stock shows strong profitability with 38.38% gross margins and 32.81% ROE, though 2025 net income declined to $883M. Analyst consensus is mixed with 68.57% hold ratings but a $203.69 price target suggesting 24% upside. Recent news highlights dividend resumption and international leadership changes.
HSY presents a value opportunity with reasonable valuation multiples (P/E 22.27) and dividend yield, but faces headwinds from cocoa cost pressures and technical weakness. The stock's investment case hinges on margin recovery and successful execution of brand investments amid competitive consumer staples landscape.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Globus Medical Inc. Class A Common Stock
Globus Medical, Inc. develops and manufactures medical devices for treating musculoskeletal disorders, including spine, orthopedic trauma, and neurosurgical products. It operates in US and internationally, serving surgeons and healthcare providers.
Read more on GMED →About Hershey Co
Hershey is a leading confectionery manufacturer in the U.S. (around a $25 billion market), controlling around 46% of the domestic chocolate space (per IRI). Beyond its namesake label, the firm's mix has expanded over the last 85 years and now consists of 100 brands, including Reese's, Kit Kat, Kisses, and Ice Breakers. Hershey's products are sold in about 80 countries, albeit with just a high-single-digit percentage of sales coming from markets outside the U.S., including Brazil, India, and Mexico. The firm has sought inorganic opportunities to extend its reach beyond its core confection business, adding Amplify Snack Brands and its Skinny Pop ready-to-eat popcorn to its mix and Pirate Brands (including the Pirate's Booty, Smart Puffs, and Original Tings brands) over the past few years.
Read more on HSY →
